PRIME THERAPUETICS data breach

Clerk's notes

Prime Therapeutics, a company that manages prescription drug benefits, officially reported a data breach to the Illinois Attorney General on November 11, 2025. This filing indicates that an incident occurred where unauthorized parties may have gained access to information within their systems.

While the specific categories of data involved were not detailed in the public record, the nature of Prime Therapeutics' business means they typically handle sensitive personal information. If you received a data breach notification letter from Prime Therapeutics, it is a direct indication that your personal information was likely involved in this incident.

The breach is currently under investigation. This means authorities and the company are working to understand the full scope of the incident, including what data was exposed and how many individuals were impacted. The outcome of this investigation will help clarify the extent of the compromise.

For those affected, the most crucial first step is to carefully read any notification letter you received from Prime Therapeutics. This letter should provide specific details about the incident and may include guidance on protective measures, such as credit monitoring services.

Beyond reviewing your notification, it's advisable to remain vigilant. Regularly check your financial statements and credit reports for any suspicious activity. If you are concerned about the exposure of your personal information, you may wish to consider consulting with a legal professional. Your rights regarding this data breach can be discussed in a free case review.

If a notification letter about this breach reached you, see every Illinois data breach on file or browse all cases.